In January 2025, Gornitzky & Co. merged with Horn & Co., the latter well known for its life sciences licensing and high-tech deal credentials. The practice advises start-ups from the cybersecurity, digital health, AI, defence-tech, food-tech, and agro-tech sectors on seed funding and Series A and B rounds. Yuval Horn acts for biotech, pharmaceutical, medical device, and digital health sector clients, and Shlomo Landress assists with IP-related transactions. Keren Kanir, Daniel Marcus, Eyal Raz, Itamar Mei-Zahav, and Dan Fisher are other key figures.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The merger with Horn & Co. has enhanced client relationships, combining Horn’s unrivalled licensing and hi-tech expertise, led by Yuval Horn, with Gornitzky’s scale, multidisciplinary resources, and international reach.’
- ‘The team, including the associates, is impressive - responsive, detail oriented, and pragmatic.’
- ‘The merger means continuity with trusted advisers who understand clients’ business, and are now backed by the resources to handle transactions of unprecedented scale and complexity.’
- ‘What makes them stand out is their ability to bridge science and law. They understand the science, the regulatory landscape, and the commercial realities, and translate all of that into practical, enforceable agreements that protect clients’ interests and help portfolio companies grow.’
- ‘No other firm in Israel combines such deep life sciences expertise with international sophistication and a truly client-focused approach.’
- ‘They are collaborative, accessible, and consistently deliver solutions that reflect a deep understanding of both clients’ business and the broader life sciences ecosystem. It is this combination of technical excellence, commercial awareness, and client focus that makes Gornitzky’s team unique in the market.’
- ‘Yuval Horn is without question one of the leading figures in Israel’s life sciences legal market. Yuval’s strength lies in his ability to bridge science, law, and business - he understands the regulatory and commercial context as well as the legal framework, and translates that into clear, practical advice.’
- ‘Yuval Horn’s foresight and ability to anticipate challenges sets him apart from competitors and gives clients great confidence in his guidance.’
- As clients of Horn & Co., we were pleased to see the team join forces with Gornitzky, one of Israel’s most established and respected firms. The merger has enhanced the relationship — combining Horn’s unrivaled licensing and high-tech expertise, led by Yuval Horn, with Gornitzky’s scale, multidisciplinary resources, and international reach. For us, this means continuity with trusted advisors who understand our business, now backed by the resources to handle transactions of unprecedented scale and complexity. What makes them stand out is their ability to bridge science and law. They understand the science, the regulatory landscape, and the commercial realities, and translate all of that into practical, enforceable agreements that protect our interests and help our portfolio companies grow. In our experience, no other firm in Israel combines such deep life sciences expertise with international sophistication and a truly client-focused approach.
- Very professional, good availability, no wasting time.
Key clients
- Group 11 Bridgewise Boston Scientific Corporation Rapyd Financial Networks (2016) V-Wave Ibex Israel VC Pontifax Venture Capital Fund Tal Ventures Ingredion Samsung Venture Investment Company Eitan Medical The INX Digital Company Ossio aMoon Luminescent Heat Engine Nugen Lutris Pharma Deliverider QuBind Technologies Corp A.R. Guide In Medical Aignostics INX IMAPTO Surgiai Blaze Review Diagnostic Robotics Panaxia Pharmaceutical Industries Guangzhou Sino-Israel Bio-Industry Investment Fund II Molex Solutions xPlan AI Terra Group Robert Bosch Dagesh Group Findig StyleTech Studio Coacher Coolautomation Endo GI Medical Virility Medical Isotopia Molecular Imaging Quicklizard Boring Plugins NugenX Clean Energy Heven Holdings Circular.Markets Coso Conntour Newtone Deriva.AI Plas-Free Solarium Car Kinoa Labs Tehiru Space Technologies GNX Data Systems Wise Road Capital Ludeo (aka Edge Gaming) Nano 24 Tsahi Merkur KCK GenieLabs Priority Software Sensorz Microsoft Global Finance EasyWork GB Bittax Catalyst IV Fund BOS Better Online Solutions General Robotics Newbolt Eviation Aircraft Makalu Optics Decodea
Work highlights
Advised V-Wave (as Israeli counsel) on its sale to Johnson & Johnson for a total consideration of US$1.675 billion (subject to certain milestones).
Advised Xero, a global cloud accounting platform formed in New Zealand and publicly traded on ASX, on its merger with Melio, a private Israeli fintech company operating in the US.
Acted for Boston Scientific Corporation (as Israeli counsel) on its definitive agreement to acquire SoniVie, a privately held med-tech company.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Yuval Horn
Other key lawyers
Shlomo Landress; Keren Kanir; Daniel Marcus; Eyal Raz; Itamar Mei-Zahav; Dan Fisher; Alon Rom; Shimrit Roznek